Natasa Milivojevic

Title: Natasa Milivojevic: Innovator in Psychostimulant Addiction Treatment

Introduction

Natasa Milivojevic is a prominent inventor based in Ljubljana, Slovenia. She has made significant contributions to the pharmaceutical industry, particularly in the treatment of psychostimulant addiction. Her innovative approach addresses critical issues related to cocaine addiction and other stimulant dependencies.

Latest Patents

Natasa Milivojevic holds a patent for a novel method for the treatment of psychostimulant addiction. This invention specifically targets cocaine addiction and involves the use of 9,10-didehydro-N-methyl-N-(2-propyl)-6-methyl-8β-aminomethylergoline. The patent outlines a therapeutically effective amount of this compound, which can be administered in its free base form or as a pharmaceutically acceptable addition salt, particularly the bimaleate salt. The invention also encompasses pharmaceutical compositions containing this active substance, aimed at reducing abstinence symptoms and cravings associated with cocaine withdrawal.

Career Highlights

Natasa Milivojevic is associated with Lek Pharmaceuticals D.d., a leading company in the pharmaceutical sector. Her work focuses on developing effective treatments for addiction, showcasing her commitment to addressing public health challenges.

Collaborations

Natasa has collaborated with notable colleagues, including Igor Krisch and Marko Zivin, to advance her research and innovations in the field of addiction treatment.

Conclusion

Natasa Milivojevic's contributions to the treatment of psychostimulant addiction highlight her role as a key innovator in the pharmaceutical industry. Her patent represents a significant step forward in addressing the challenges of addiction, particularly cocaine dependency.